A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry - Report - MDSpire

A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry

Voters will decide whether to expand lawmakers' authority to tax currently exempt healthcare goods and services, raising concerns about patient costs and healthcare access.

  • By

  • Bram Sable-Smith

  • July 16, 2026

  • 6 min

Share

A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry

Overview

Missouri voters will soon decide on a proposed amendment that could allow the legislature to impose sales taxes on healthcare services and prescription drugs, currently exempt from taxation.

Background

The proposed constitutional amendment in Missouri aims to replace the state’s income tax with expanded sales taxes, potentially affecting healthcare services and prescription medications. This shift raises concerns among healthcare advocates about the affordability and accessibility of necessary medical care for residents.

Data Highlights

No numerical or trial data available in the source material.

Key Findings

  • Missouri currently exempts prescription drugs and doctor visits from sales taxes.
  • The proposed amendment could lead to new taxes on healthcare services, which are unusual in the U.S.
  • Critics argue that the amendment could result in significant cuts to state services if income tax revenue is lost.
  • Proponents believe the tax cut could spur economic growth, although concerns about healthcare taxation persist.
  • Federal law prohibits states from taxing many healthcare services covered by Medicare and Medicaid.

Clinical Implications

Healthcare professionals should be aware of the potential financial implications for patients if sales taxes are imposed on healthcare services.

Conclusion

The outcome of the proposed tax amendment in Missouri requires attention from healthcare providers and policymakers.

Related Resources & Content

  1. Conexiant, Urgent Care, Unchecked Power, 2023 -- Urgent Care, Unchecked Power
  2. Ophthalmology Management, Viewpoint, 2016 -- Viewpoint
  3. ADA News, 2025 -- ADA: Urge Congress to protect dentists from unfair tax hike
  4. JACC, 2025 -- 2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines
  5. Diabetes Care, 2026 -- Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2026
  6. ASCO, 2025 -- Recommendations to Reduce Out-of-Pocket Costs for People with Cancer Detailed
  7. PubMed, 2024 -- ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer
  8. JAMA Internal Medicine, 2026 -- Cost-Related Medication Nonadherence Before and After the 2024 Inflation Reduction Act Provisions
  9. Ophthalmology Management — Should You Opt Out of Medicare?
  10. 2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | JACC
  11. 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
  12. Recommendations to Reduce Out-of-Pocket Costs for People with Cancer Detailed in New ASCO Position Statement - ASCO
  13. ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer - PubMed
  14. Cost-Related Medication Nonadherence Before and After the 2024 Inflation Reduction Act Provisions | Clinical Pharmacy and Pharmacology | JAMA Internal Medicine | JAMA Network
  15. Scholars@Duke publication: Interventions addressing cost-related medication nonadherence in diabetes: a scoping review.
  16. Medicare Advantage and Medicare Prescription Drug Programs to Remain Stable as CMS Implements Improvements to the Programs in 2025 | CMS
  17. 2025 Medicare Advantage and Part D Rate Announcement | CMS
  18. https://uscode.house.gov/view.xhtml?edition=prelim&path=%2Fprelim%40title42%2Fchapter7%2Fsubchapter18%2FpartD%2Fsubpart1&utm_source=openai
  19. Inflation Reduction Act Research Series: Projecting the Impact of the $2,000 Part D Out-Of-Pocket Cap for Medicare Part D Enrollees with High Prescription Drug Spending | ASPE

Original Source(s)

A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry

  • by Bram Sable-Smith

  • July 16, 2026

Related Content

From clinician to coach: promoting early relational health and language development in primary pediatric care

FDA Approves Subcutaneous Isatuximab-irfc

The approval expands subcutaneous use across newly diagnosed and previously treated multiple myeloma.

Breastfeeding May Help Infants Achieve Adequate Sleep

A nationwide birth cohort found lower odds of short sleep at 1 year among infants breastfed during the first 6 months of life, regardless of formula supplementation.